GMO Emerging Markets R6 (GEMNX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.95: the stock has moved about 5% less than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerGMO Emerging Markets R6 (GEMNX) trades at $41.59. GMO Emerging Markets R6 is a fund focused on investing in emerging market companies. It allocates at least 80% of its net assets to companies tied economically to emerging markets. Sector: Financials.
Price as of · Last analyzed: Mar 17, 2026Analyst Coverage for GEMNX: GEMNX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
GMO Emerging Markets R6 (GEMNX) Financial Services Profile
GMO Emerging Markets R6 is an asset management fund focusing on companies tied to emerging markets, allocating a minimum of 80% of its net assets. With a market capitalization of $0.53 billion and a beta of 0.95, the fund operates within the financial services sector, offering investors exposure to emerging market economies.
What Is the Investment Thesis for GEMNX?
GMO Emerging Markets R6 presents an investment opportunity for those seeking exposure to emerging market equities. With a market capitalization of $0.53 billion and a beta of 0.95, the fund offers a diversified approach to investing in developing economies. The fund's strategy of allocating at least 80% of its net assets to companies tied to emerging markets provides a focused approach to capturing growth in these regions. Key value drivers include the potential for long-term economic growth in emerging markets and the fund's ability to identify undervalued companies. Catalysts for growth include increasing consumer spending in emerging economies and advancements in technology and infrastructure. Potential risks include political instability, currency fluctuations, and economic downturns in emerging markets. Investors may want to evaluate these factors when evaluating the fund's potential for long-term returns.
Based on FMP financials and quantitative analysis
GEMNX Key Highlights
The fund invests at least 80% of its net assets in companies tied economically to emerging markets.
- The fund has a market capitalization of $0.53 billion.
- The fund's beta is 0.95, indicating moderate volatility relative to the market.
- The fund does not offer a dividend yield.
- The fund invests in securities of companies of any market capitalization.
Who Are GEMNX's Competitors?
GEMNX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ARGVX One Choice 2060 Portfolio - Investor Class | $17.43 | +0.69% | $438M | — |
| CMJAX Calvert US Mid Cap Core Rspnb Idx A | $49.93 | +0.62% | $492M | — |
| CMJIX Calvert US Mid Cap Core Rspnb Idx I | $50.54 | +0.60% | $492M | — |
| EXHAX Manning & Napier Fd, Inc. Pro-Blend Maximum Term Srs Cl S | $26.71 | +0.64% | $401M | — |
| FSRBX Fidelity Select Banking Portfolio | $35.76 | +0.82% | $450M | — |
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | 51 5-pillar |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are GEMNX's Key Strengths?
Experienced investment management team.
- Disciplined, value-oriented investment strategy.
- Access to GMO's proprietary research and resources.
- Focus on emerging markets with high growth potential.
What Are GEMNX's Weaknesses?
Exposure to political and economic risks in emerging markets.
- Potential for currency fluctuations to impact returns.
- Dependence on the performance of emerging market economies.
- Fund size may limit investment flexibility.
What Are the Key Risks for GEMNX?
Economic slowdown in major emerging markets impacting fund performance.
- Geopolitical instability and political risks in certain emerging market countries.
- Currency fluctuations negatively affecting investment returns.
- Regulatory changes and increased compliance costs in the financial services sector.
- Increased competition among asset management firms driving down fees.
What Are GEMNX's Competitive Advantages?
- Established brand reputation of GMO.
- Disciplined, value-oriented investment strategy.
- Experienced investment management team.
- Access to GMO's proprietary research and resources.
What Does GEMNX Do?
GMO Emerging Markets R6 is a fund managed by GMO, a well-established investment firm with a history of focusing on long-term investment strategies. The fund is designed to provide investors with exposure to companies economically tied to emerging markets, as defined by those not included in the MSCI World Index as developed markets. Established with the goal of capturing growth opportunities in developing economies, the fund invests both directly and indirectly in companies of varying market capitalizations, utilizing strategies such as investing in underlying funds or derivatives to achieve its investment objectives. The fund's investment approach emphasizes a disciplined, value-oriented strategy, seeking to identify companies that are undervalued relative to their long-term growth potential. GMO's research-driven process involves in-depth analysis of macroeconomic trends, industry dynamics, and company-specific factors to construct a diversified portfolio of emerging market equities. The fund's geographic reach spans across numerous emerging economies, including those in Asia, Latin America, Eastern Europe, and Africa. GMO Emerging Markets R6 competes with other asset management firms offering similar emerging market investment products. However, GMO differentiates itself through its commitment to rigorous research, a long-term investment horizon, and a focus on downside protection. The fund aims to deliver superior risk-adjusted returns over the long term by capitalizing on inefficiencies in emerging market equities.
What Products and Services Does GEMNX Offer?
- Invests in companies tied economically to emerging markets.
- Allocates at least 80% of its net assets to emerging market companies.
- Invests directly and indirectly in emerging market companies.
- Invests in securities of companies of any market capitalization.
- Utilizes underlying funds or derivatives to achieve investment objectives.
- Seeks to identify undervalued companies with long-term growth potential.
How Does GEMNX Make Money?
- Generates revenue through investment management fees.
- Invests in a diversified portfolio of emerging market equities.
- Employs a value-oriented investment strategy.
- Conducts in-depth research to identify investment opportunities.
What Industry Does GEMNX Operate In?
The asset management industry is highly competitive, with numerous firms offering a wide range of investment products. Emerging market funds, like GMO Emerging Markets R6, compete with other funds focused on specific regions or investment strategies. The industry is influenced by macroeconomic trends, regulatory changes, and investor sentiment. The growth of emerging markets is expected to drive demand for emerging market investment products. GMO Emerging Markets R6 operates in this landscape, differentiating itself through its investment approach and risk management strategies. Competitors include ARGVX, CMJAX, CMJIX, EXHAX, and FSRBX.
Who Are GEMNX's Key Customers?
- Institutional investors seeking exposure to emerging market equities.
- Individual investors seeking diversification in their investment portfolios.
- Financial advisors seeking investment solutions for their clients.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
GEMNX Financials
Bull Case vs Bear Case
Bull Case
- Experienced investment management team.
- Disciplined, value-oriented investment strategy.
- Access to GMO's proprietary research and resources.
- Focus on emerging markets with high growth potential.
Bear Case
- Exposure to political and economic risks in emerging markets.
- Potential for currency fluctuations to impact returns.
- Dependence on the performance of emerging market economies.
- Fund size may limit investment flexibility.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
GEMNX Latest News
No recent news available for GEMNX.
GEMNX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GEMNX.
Price Targets
Wall Street price target analysis for GEMNX.
GEMNX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GEMNX; grades run from A+ (80-100) to F (below 30).
What Investors Ask About GMO Emerging Markets R6 (GEMNX) — Financials
What are the main risks for GEMNX?
Investing in GMO Emerging Markets R6 carries several risks inherent to emerging markets. Economic risks include potential slowdowns in emerging market growth, impacting company earnings and valuations. Currency fluctuations can erode the value of investments when returns are translated back into the investor's home currency.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.